Vir Biotechnology Archives - Express Pharma

FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant

Drugmakers and scientists begin hunt for long COVID treatments

Vir Biotechnology announces maiden marketing authorisation for sotrovimab in Australia

Vir, GSK to seek EUA for COVID-19 antibody therapy

Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective response

Alnylam’s gene-silencing efforts get $2 billion Blackstone backing